Hydralazine hydrochloride (Macuclear)

N/A

Report date: 2026/03/16 20:01:47

Base Information

Drug NameHydralazine hydrochloride (Macuclear)
Drug Alias NameMC-1101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAmine oxidase, copper containing inhibitors
TargetsAmine oxidase, copper containing
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMacuclear Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMacuclear Inc
Active IndicationsN/A
Inactive IndicationsMacular Degeneration

Other Information

ATC CodeN/A
Related LinksN/A